Ensuring everyone in the world gets a COVID vaccine
7 global health experts from Africa, Latin America, Asia and the U.S. talk about their continents' unique issues
As the race to produce and roll out COVID-19 vaccines around the world continued to ramp up in the first month of 2021, global health experts from four continents met with DGHI to discuss vaccine equity and allocation.
An interview with Geeta Swamy on the safety of COVID vaccines
Duke University School of Medicine Dean Mary E. Klotman, MD, interviews Associate Professor of OB-GYN and Vice Dean for Scientific Integrity Geeta Swamy, MD, about the safety and possible side effects of the COVID-19 vaccine.
[video:https://youtu.be/9EtHtFpt2M0]
School of Medicine Students Volunteer in Duke’s COVID-19 Vaccine Clinic
Duke medical and health professions students are playing a prominent role in the distribution of COVID-19 vaccines to the Duke Health community.
More than 100 students from the School of Medicine have volunteered to assist with the administration of the vaccines at Duke vaccination sites. As of January 13, 2021, more than 18,000 vaccinations have been administered to Duke Health employees. Last week, Duke began vaccinating community members over the age of 75.
LATIN-19 Co-founders discuss COVID-19's impact on the Latinx community
Duke University School of Medicine Dean Mary E. Klotman, MD, talks with co-founders of Duke’s LATIN-19 initiative Viviana S. Martinez-Bianchi, MD, Associate Professor of Family Medicine and Community Health, and Gabriela Maradiaga Panayotti, MD, Assistant Professor of Pediatrics, about the impact of the COVID-19 pandemic on the Latinx community and LATIN-19’s organized efforts to advocate for needs of this community of people.
Five questions about the COVID vaccines
Dr. Susanna Naggie has some reassuring facts to share
With two vaccines being rolled out under emergency use approval from the Food and Drug Administration, health care workers and others with high risk of COVID exposure are now being vaccinated at Duke and elsewhere around the country.
We asked infectious disease specialist Dr. Susanna Naggie of the Duke University School of Medicine to answer some of the common questions the public has been raising about these vaccines.
Duke faculty & residents respond to COVID-19 among people without housing
Since March, Jacob Feigal, MD, a medical instructor in the Departments of Psychiatry and Medicine, and Nicholas Turner, MD, MHSc, a medical instructor in the Department of Medicine, have been collaborating with city and county stakeholders to mitigate the impact of COVID-19 among individuals suffering from homelessness.
Governor Cooper visits Duke University School of Medicine
Cooper thanks frontline workers as they receive their vaccinations
On Monday, Governor Roy Cooper visited the Duke University School of Medicine to tour the COVID-19 vaccination area. He was greeted at the door by Faye Williams, a retired VA nurse and now visitor screener at Duke, who was the first person in the Triangle to receive a COVID-19 vaccination.
Cooper greeted and thanked many Duke Health employees as he made his way through the School of Medicine to the vaccination area.
DCRI, Verily, and HERO Registry to support long-term safety study of COVID-19 vaccine
The Duke Clinical Research Institute (DCRI) and Verily are utilizing the HERO Registry and community to launch a study to gain long-term insights about the COVID-19 vaccine developed by Pfizer and BioNTech, including real-world safety data. This study, which is funded by Pfizer, will follow vaccinated healthcare workers for two years to assess their experiences after receiving the vaccine.
Clinician feedback helps basic scientists determine COVID-19 research priorities
A team of Duke scientists and clinicians are working together to bridge the knowledge gap between patient care and basic science research associated with COVID-19.
Emily Ko, MD, PhD, assistant professor of medicine and hospitalist at Duke Regional Hospital, recently developed and distributed a survey to clinicians working on the frontlines, asking them about what they’ve observed in terms of patient symptoms, complications, infection, and re-infection in hospitalized patients with COVID-19.
Barton Haynes answers the essential questions about the COVID vaccine
Director of Duke Human Vaccine Institute on the safety and efficacy of the vaccine and what comes next
Dr. Barton Haynes received his first dose of the COVID-19 vaccine Wednesday with the confidence of a researcher who has spent his entire career studying the science of vaccines.